Genetic studies of elderly individuals at high-risk for AD (APOE ε4 carriers) who escaped the disease, identified a rare Rab10 variant as a potential provider of molecular resilience against AD (Ridge et al., 2017). Here, RAB10 is linked to Alzheimer disease.